Rho-Kinase Pathway in Pulmonary Fibrosis
Description: RELEVANCE (See instructions): Idiopathic pulmonary fibrosis is a lethal disease ofthe lung with no effective therapies. This project evaluates the efficacy of a novel therapeutic approaches in an animal model of lung fibrosis that more closely resembles human IPF.
Funding type: program
Funder scheme: P50
Start date: 2011-05-01
End date: 2014-04-30
Investigator: VICTOR J. THANNICKAL (lead)
Institution: University of Alabama at Birmingham
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Funded outputs count: 11
Funder award ID: P50HL107181
OpenAlex ID: G6184450286
